alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5


<S>                             <C>
<PERIOD-TYPE>                     9-MOS
<FISCAL-YEAR-END>                            SEP-30-1999
<PERIOD-START>                               SEP-30-1998
<PERIOD-END>                                 JUN-30-1999
<CASH>                                           496,320
<SECURITIES>                                           0
<RECEIVABLES>                                    359,360
<ALLOWANCES>                                      95,125
<INVENTORY>                                    1,036,185
<CURRENT-ASSETS>                               3,246,445
<PP&E>                                         1,577,662
<DEPRECIATION>                                   374,079
<TOTAL-ASSETS>                                 7,850,319
<CURRENT-LIABILITIES>                          1,304,997
<BONDS>                                                0
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                          500
<COMMON>                                             815
<OTHER-SE>                                     5,002,421
<TOTAL-LIABILITY-AND-EQUITY>                   7,850,319
<SALES>                                        3,250,976
<TOTAL-REVENUES>                               3,250,976
<CGS>                                          2,274,825
<TOTAL-COSTS>                                  2,274,825
<OTHER-EXPENSES>                               1,810,052
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                                28,894
<INCOME-PRETAX>                                 (858,364)
<INCOME-TAX>                                    (171,672)
<INCOME-CONTINUING>                             (686,692)
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                    (686,692)
<EPS-BASIC>                                      (0.09)
<EPS-DILUTED>                                      (0.09)



</TABLE>
IA 

115TH CONGRESS 

2D SESSION H. J. RES. 126 

Proposing an amendment to the Constitution of the United States relating 

to contributions and expenditures with respect to Federal elections. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 19, 2018 

Mr. YARMUTH (for himself and Mr. COHEN) submitted the following joint 

resolution; which was referred to the Committee on the Judiciary 

JOINT RESOLUTION 

Proposing an amendment to the Constitution of the United 

States relating to contributions and expenditures with 

respect to Federal elections. 

1 Resolved by the Senate and House of Representatives 

2 of the United States of America in Congress assembled (two3 thirds of each House concurring therein), That the fol4 lowing article is proposed as an amendment to the Con5 stitution of the United States, which shall be valid to all 

6 intents and purposes as part of the Constitution when 

7 ratified by the legislatures of three-fourths of the several 

8 States within seven years after the date of its submission 

9 for ratification: 


sradovich on DSK3GMQ082PROD with BILLS
2 

•HJ 126 IH 

1 ‘‘ARTICLE— 

2 ‘‘SECTION 1. Financial expenditures, or in-kind 

3 equivalents, with respect to a candidate for Federal office, 

4 without regard to whether or not a communication ex5 pressly advocates the election or defeat of a specified can6 didate in the election, shall not constitute protected 

7 speech, as guaranteed by this Constitution or any amend8 ment to this Constitution. 

9 ‘‘SECTION 2. Congress shall have the power to enact 

10 a mandatory public financing system to provide funds to 

11 qualified candidates in elections for Federal office, which 

12 shall be the sole source of funds raised or spent with re13 spect to Federal elections. 

14 ‘‘SECTION 3. Congress shall have power to enforce 

15 the provisions of this article by appropriate legislation.’’. 

Æ 


sradovich on DSK3GMQ082PROD with BILLS
```

[Congressional Record Volume 155, Number 6 (Monday, January 12, 2009)]
[Senate]
[Page S300]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                     TRIBUTE TO SENATOR ROBERT BYRD

  Mr. COCHRAN. Mr. President, I am pleased to join with my colleagues 
in congratulating Senator Robert Byrd on his 50 years of exemplary and 
distinctive service in the U.S. Senate.
  Senator Byrd is a distinguished Member of the Senate and has served 
in many important positions of responsibility in this body during his 
tenure as Senator from West Virginia. He has served as minority and 
majority leader, as chairman and ranking member of the Appropriations 
Committee, and as President pro tempore of the Senate.
  It has been a great privilege to serve with Senator Byrd on the 
Appropriations Committee. I have learned so much from him since joining 
this committee in 1981. Senator Byrd has been a good friend as well as 
a mentor. It has also been a great pleasure to serve with him on the 
Homeland Security Appropriations Subcommittee, which we have both 
chaired.
  I look forward to continuing to serve with him in the coming years.

                          ____________________
```
```

[Congressional Record Volume 155, Number 7 (Tuesday, January 13, 2009)]
[House]
[Page H165]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                 DESIGNATION OF THE SPEAKER PRO TEMPORE

  The SPEAKER pro tempore laid before the House the following 
communication from the Speaker:

                                               Washington, DC,

                                                 January 13, 2009.
       I hereby appoint the Honorable Donna F. Edwards to act as 
     Speaker pro tempore on this day.
                                                     Nancy Pelosi,
     Speaker of the House of Representatives.

                          ____________________
```
```

[Federal Register Volume 89, Number 226 (Friday, November 22, 2024)]
[Notices]
[Pages 92695-92696]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-27363]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the

[[Page 92696]]

provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Cell and Gene Therapies for HIV 
Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed).
    Date: December 16-18, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G11, 
Rockville, MD 20892.
    Contact Person: J. Bruce Sundstrom, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G11, 
Rockville, MD 20892, 240-669-5045, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-27363 Filed 11-21-24; 8:45 am]
BILLING CODE 4140-01-P
```
<TABLE> <S> <C>

  <ARTICLE>       5
  <LEGEND>
  This schedule contains summary financial information extracted from the
  Condensed Consolidated Statement of Financial Condition at December 31,
  1996
  (Unaudited) and the Condensed Consolidated Statement of Income for the
  Year
  Ended December 31, 1996 (Unaudited) and is qualified in its entirety by
  reference to such financial statements.
  </LEGEND>
  <MULTIPLIER>    1
         
  
  <S>                           <C>
  <PERIOD-TYPE>                 YEAR
  <FISCAL-YEAR-END>                         Dec-31-1996
  <PERIOD-START>                            Jan-01-1996
  <PERIOD-END>                              Dec-31-1996
  <CASH>                                        154,137
  <SECURITIES>                                        0
  <RECEIVABLES>                                       0
  <ALLOWANCES>                                        0
  <INVENTORY>                                         0
  <CURRENT-ASSETS>                                    0
  <PP&E>                                              0
  <DEPRECIATION>                                      0
  <TOTAL-ASSETS>                                256,837
  <CURRENT-LIABILITIES>                               0
  <BONDS>                                             0
  <PREFERRED-MANDATORY>                               0
  <PREFERRED>                                         0
  <COMMON>                                      314,080
  <OTHER-SE>                                          0
  <TOTAL-LIABILITY-AND-EQUITY>                  256,837
  <SALES>                                             0
  <TOTAL-REVENUES>                              383,405
  <CGS>                                               0
  <TOTAL-COSTS>                                       0
  <OTHER-EXPENSES>                              177,920
  <LOSS-PROVISION>                                    0
  <INTEREST-EXPENSE>                                  0
  <INCOME-PRETAX>                               205,485
  <INCOME-TAX>                                        0
  <INCOME-CONTINUING>                                 0
  <DISCONTINUED>                                205,485
  <EXTRAORDINARY>                                     0
  <CHANGES>                                           0
  <NET-INCOME>                                  205,485
  <EPS-PRIMARY>                                    0.03
  <EPS-DILUTED>                                    0.03
          
  
  
  
</TABLE>
Amendment No.1 to Raytheon 2010 Stock Plan



  
 Exhibit 10.1

 RAYTHEON 2010 STOCK PLAN 
 AMENDMENT # 1 
 By vote of the Management Development and Compensation Committee affirmed
by the Board of Directors, effective September 23, 2010, the Raytheon 2010 Stock Plan is amended by deleting Section 4.8 in its entirety and by substituting in lieu thereof the following: 

4.8 Committee means the Management Development and Compensation Committee (“MDCC”) of the Company’s
Board, or any subcommittee of the MDCC to which the MDCC may from time to time delegate its authority and responsibility under the Plan; provided, however, that the “Committee” in regard to exercising any authority and responsibility to
grant Awards under the Plan to Participants who are Directors and to make or take, as the case may be, all required or appropriate determinations and actions in respect of such grants shall mean the Governance and Nominating Committee of the
Company’s Board or another Board committee or the Board itself, if so determined by the Board.
No. 91-6082.

#### Kelly *v.*Trickey et al.

C. A. 8th Cir. Certiorari denied.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          NOV-30-1996
<PERIOD-START>                             DEC-01-1996
<PERIOD-END>                               FEB-28-1997
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                  139,033
<ALLOWANCES>                                    20,067
<INVENTORY>                                    117,236
<CURRENT-ASSETS>                               574,740
<PP&E>                                         325,223
<DEPRECIATION>                                  52,931
<TOTAL-ASSETS>                               1,671,074
<CURRENT-LIABILITIES>                        3,221,925
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        500
<COMMON>                                            87
<OTHER-SE>                                 (1,551,438)
<TOTAL-LIABILITY-AND-EQUITY>               (1,671,074)
<SALES>                                        215,525
<TOTAL-REVENUES>                               215,525
<CGS>                                          106,267
<TOTAL-COSTS>                                  372,301
<OTHER-EXPENSES>                                68,418
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              33,418
<INCOME-PRETAX>                              (255,194)
<INCOME-TAX>                                  (38,282)
<INCOME-CONTINUING>                          (186,912)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (186,912)
<EPS-PRIMARY>                                   (0.21)
<EPS-DILUTED>                                   (0.21)
        

</TABLE>
Page 1 of 2 

Occupational Safety And Health Review Commission

Commissioners’ Monthly Docket Report at Close of Business on June 30, 2023 

 DOCKET

NUMBER

RESPONDENT'S

NAME

DOCKETED TYPE* BRIEFING

NOTICE 

DATE

BRIEFING 

STATUS

COMMISSIONER 

NOT 

PARTICIPATING

1 18-0701 Midvale Paper Box 

Company, Inc. 10/21/21 DFR 11/09/21 Closed

2 20-0653

Eastern Gas 

Transmission and 

Storage, Inc.

10/28/21 DFR 11/05/21 Closed

3 19-0622 Anthony Marano Co. 02/10/22 DFR 02/16/22 Closed

4 20-0541 Harvey Builders d/b/a 

Harvey Cleary Builders 03/03/22 DFR 03/11/22 Closed

5 21-0432 Ariana Murrell-Rosario 

d/b/a Liberty Tax Service 07/01/22 DFR 07/13/22 Closed

6 20-1212 Roy Rock, LLC 07/14/22 DFR 07/15/22 Closed

7 20-0232 U.S. Ceiling Corp. 09/29/22 DFR 10/05/22 Closed

8 21-0794 U.S. Postal Service –

Canovanas Post Office 11/16/22 DFR 11/18/22 Closed

9 20-0032 UHS of Fuller, Inc.,

UHS of Delaware, Inc. 03/02/23 DFR 03/20/23 Open

10 21-0295 Poinsett Hutterian 

Brethren, Inc. 03/16/23 DFR 03/27/23 Open

11 20-1437 K.M. Davis Contracting 

Co., Inc. 03/23/23 DFR 03/31/23 Open

12 17-0053 Joon, LLC d/b/a Ajin USA 03/23/23 DFR 03/29/23 Closed

13 20-0559 MasTec Services, Inc. 04/04/23 DFR 04/06/23 Open

14 19-1667 A Crane Rental LLC 04/27/23 DFR 04/27/23 Open

15 19-1054

Shawn D. Purvis d/b/a/ 

Purvis Home 

Improvement Co., Inc. (an 

individual) and Purvis 

Home Improvement Co., 

Inc. (in the alternative)

06/29/23 DFR 06/30/23 Open

16 19-1056

Shawn D. Purvis d/b/a/ 

Purvis Home 

Improvement Co., Inc. (an 

individual) and Purvis 

Home Improvement Co., 

Inc. (in the alternative)

06/29/23 DFR 06/29/23 Open
Page 2 of 2 

Occupational Safety And Health Review Commission

Commissioners’ Monthly Docket Report at Close of Business on June 30, 2023 

 DOCKET

NUMBER

RESPONDENT'S

NAME

DOCKETED TYPE* BRIEFING

NOTICE 

DATE

BRIEFING 

STATUS

COMMISSIONER 

NOT 

PARTICIPATING

17 19-1905

Shawn D. Purvis d/b/a/ 

Purvis Home 

Improvement Co., Inc. (an 

individual) and Purvis 

Home Improvement Co., 

Inc. (in the alternative)

06/29/23 DFR 06/29/23 Open

*DFR – Direction For Review

 REM – Appellate Remand

 INT REV – Interlocutory Review
EX-10.33





 Exhibit 10.33 

 
 



 
 7 August 2020 
 Gary A.
Pestano, PhD 
 Biodesix 
 2970 Wilderness Pl#100 

Boulder, CO 80301 
 Dear Gary, 

This letter is to inform you that Bio-Rad Laboratories grants permission for Biodesix to use the Bio-Rad ddPCR SARS-CoV-2 assay for commercial diagnostic services and without the need for the use of an additional license from Bio-Rad. 
 Regards, 
 /s/
Simon May 
 Simon May 
 SVP and General . Digital Biology
Group 
 Bio-Rad Laboratories, Inc.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEET AND CONDENSED CONSOLIDATED STATEMENT OF
OPERATIONS FOUND ON PAGES 2 AND 3 OF THE COMPANY'S FORM 10-Q FOR THE YEAR 
TO DATE AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL 
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-29-1997
<CASH>                                          16,224
<SECURITIES>                                    12,086
<RECEIVABLES>                                   17,483
<ALLOWANCES>                                         0
<INVENTORY>                                     17,415
<CURRENT-ASSETS>                                68,530
<PP&E>                                           9,344
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  77,874
<CURRENT-LIABILITIES>                           11,536
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        56,286
<OTHER-SE>                                      10,052
<TOTAL-LIABILITY-AND-EQUITY>                    77,874
<SALES>                                         29,594
<TOTAL-REVENUES>                                29,594
<CGS>                                           14,723
<TOTAL-COSTS>                                   14,723
<OTHER-EXPENSES>                                16,486
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  (768)
<INCOME-TAX>                                     (255)
<INCOME-CONTINUING>                              (513)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (513)
<EPS-PRIMARY>                                    (.04)
<EPS-DILUTED>                                    (.04)
        

</TABLE>
No. 82-874.

#### Schweiker, Secretary of Health and Human Services *v.*Edwards.

C. A. 9th Cir. Motion of respondent for leave to proceed *in forma pauperis*and cer-tiorari granted.
No. 90-715.

#### Grushkin *v.*Santa Clara Superior Court.

Ct. App. Cal., 6th App. Dist. Certiorari denied.
EXHIBIT 32.2
  CERTIFICATION PURSUANT TO
 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO
 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  In connection with the Annual Report of Emtec, Inc. (the “Company”) on Form 10-K for the period ending August 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory P. Chandler, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/ Gregory P. ChandlerGregory P. ChandlerChief Financial OfficerDecember 14, 2011
#### Maryland Casualty Company of Baltimore, Respondent, vs. Johnson, Appellant.

*April 8*

May *11, 1926.*

Companion case to *Fidelity & Casualty Co. v. Johnson, ante,*p. 199.

Appeal from an order of the circuit court for Dane county: August C. Hoppmann, Circuit Judge.

*Affirmed.*

For the appellant there was a brief by the *Attorney General*and *T. L. McIntosh,*assistant attorney general, and oral argument by *Mr. McIntosh.*

For the respondent there was a brief by *McGovern, Lyons, Curtis, Devos & Reiss*of Milwaukee, and oral argument by *F. E. McGovern.*

Rosenberry, J.

This case is a companion case to *Fidelity & Casualty Company of New York v. Johnson, ante,*p. 199, 208 N. W. 791, and for the reasons there stated the mandate in this case will be the same as in that.

*By the Court.*— The order appealed from is affirmed.

Stevens, J., took no part.
<PAGE>

                                                                      Exhibit 11

                              POLYMER GROUP, INC.

                       COMPUTATION OF EARNINGS PER SHARE
                     (In Thousands, Except Per Share Data)

<TABLE>
<CAPTION>
                                              Three Months
                                                 Ended        Six Months Ended
                                            ----------------- -----------------
                                            June 30,  July 1, June 30,  July 1,
                                              2001     2000     2001     2000
                                            --------  ------- --------  -------
<S>                                         <C>       <C>     <C>       <C>
Basic:
  Net income (loss)........................ $(13,035) $ 1,420 $(31,619) $ 3,557
  Average common shares outstanding........   32,004   32,004   32,004   32,003
  Net income (loss) per common share--
   basic................................... $  (0.41) $  0.04 $  (0.99) $  0.11
Diluted:
  Net income (loss)........................ $(13,035) $ 1,420 $(31,619) $ 3,557
  Average common shares outstanding........   32,004   32,004   32,004   32,076
  Net income (loss) per common share--
   diluted................................. $  (0.41) $  0.04 $  (0.99) $  0.11
</TABLE>